Dutech Holdings

Grass Is Always Greener On The Other Side… + CDW Holdings FY16Q4, TTI’s Thoughts

I did say there’ll be the occasional travel pics.

475) Austria.jpg

This has to be one of the most beautiful places I’ve been to. Plus my son had crazy fun here. It’s a lot colder than it looks though, and somehow as age progresses, my homeostatic system isn’t as good and I don’t do so well with cold anymore.

This was towards the end of last year in Austria, not now. Path leading to the ice caves (that’s the opening in the mountain). Boy, glad I did this. Not sure if I’ve the stamina in a few years time.

483) Ice cave path.JPG

This other pic though, is something that I find really interesting:

474) Austria goats.jpg

I was feeding these goats with grass that I tore off from the ground. As far as I can tell, the grass is EXACTLY the same type as the humongous patch just behind the goats, and yet they were all clamoring to eat grass off my hands! Like I’m feeding them “gourmet” grass!

Even after I stopped feeding them, they didn’t go back to grazing and instead, followed me while I walked around the fence.

LOL, interesting isn’t it?

This is, quite literally, a perfect example of “the grass is always greener on the other side”!

Come on, tell me I’m not a weirdo and I’m not the only one who finds this entertaining. Funny too.

In a post sometime last year, I said that I’ve resolved to cut down on leisure travelling for 2017, because I felt that I’ve kinda had too much fun, and… just generally, have been too… lazy?

It’s march now, and I think it’s safe to say… that I’ve failed.

I read a recent article that the way to truly “buy happiness”, is to buy experiences.

I couldn’t agree more. Yet, buying experiences cost $$$. And this is what I’ve been neglecting of late.

Anyway, 1 more trip to Perth is penciled in, in April and I’m done for the year. Gotta bunker down and go back to work. From some of the emails I’ve received, I think even readers of SG TTI noticed the tardiness in my posts. No analysis done = no posts!

On a different note, I received some emails, (and a comment somewhere) asking about Dutech. I’m not writing an update on Dutech’s FY16Q4 because if you look at the post categories on the right ——>

I already have several posts on Dutech, and I think it’s better to have some variety perhaps?

So in a very brief summary, for Dutech’s FY16Q4, the extraordinary earnings that they recognized from the Metric acquisition is a lot lesser than I expected. Yet, the stated the NAV and the goodwill is actually recognized accordingly in the asset side of the BS.

The balance sheet is balanced by adding in certain liabilities (that was previously not announced during the acquisition), and these liabilities relate to pension schemes and related stuff. Not surprising… Europe workers have all these pension stuff.

It doesn’t change my investing thesis though.

Yes, I’m aware CIMB has downgraded Dutech to a hold, but well, if you’d read the earlier posts here, you’d know that I generally don’t pay TOO much attention to analyst reports. They do move the markets though. That’s the reality, which is actually a good thing if you have strong FA.

For eg, a large concern flagged up (and that’s the main reason for the downgrade), is that the margins are impacted because of rising roll coil steel, as reflected in the Q4 margins y-o-y.

But literally right after the report, the steel price has since fallen somewhat. So my point is, if one keeps trying to track these and pull or add capital whenever there are all these little waves, you’d always be behind the curve.

Anyway, let me not hijack this post. This post is supposed to be about CDW Holding’s FY16 results. I’ve previously invested in CDW, but has since divested:

Post-mortem Of CDW Holding Ltd Divestment

23) CDWlogo 21052016

While I was vested though, I’ve always found CDW’s management, particularly the CFO, to be honest and straightforward in his replies. Unfortunately, the company is in a very tough spot currently, and has been in fact, for the past couple of years.

Coincidentally, while I was updating myself with CDW’s performance, NextInsight published an article on the company. NextInsight has always been a platform that I respect a lot, so obviously I try to keep myself abreast of the commentary there.


The top part of the article is mostly factual, nothing much to discuss there. The bottom part has some bullet points on the merits of the company, and while they’re all true, it doesn’t reflect the challenges facing the company. Let me try to substantiate and paint an intimate picture with this update.

Yes, the company is trading close to net cash. The BS is still rock solid too. Nobody denies that. Total bank borrowings, although increased from last year, is still very low, and their cash holdings can wipe out the borrowings completely.

That’s a good start.

476) CDW holdings BS debt.jpg

Here, we can tell that the company has always been prudent. Debt has always been very manageable.

“Market cap supported by 91% of net cash”. Sure, that may be true, and good too. But I’d also point out that cash and cash equivalents, net of debt, has been dropping over recent years, and is at the lowest level in the past 5 years:

FY12: $43.6mil

FY13: $46.5mil

FY14: $55.1mil

FY15: $46.7mil

FY16: $40.2mil

OK, granted that the BS is STILL very strong and the drop is not that great. But just thought I’d have to point this out. The BS is strong, supported by a lot of cold hard $$$, but it is also deteriorating and just a bit “less great” than before.

The company has also been buying back their shares (As stated in the NextInsight article), presumably that indicates that the management thinks their shares are currently undervalued.

Normally that’s a good thing for shareholders. In this instance though, CDW’s management also has 8,500,000 share options outstanding, with an exercise price of $0.216. This means the options are currently in-the-money.

It’s been painted as a good thing by the NI article, because presumably management will have an incentive to keep the share price above the option exercise price.

This is where I disagree. A dilutive share option scheme is never a good thing for shareholders. Plus, this brings up some doubt as to whether share buybacks are done right now because the shares are really undervalued, or are they done to support the issuing of shares from the exercising of options.

Anyhow, it’s only 8.5mil outstanding share options so it’s not a game changing event either.

The earnings have really come down hard in FY16. Things are not good at an operational level:

477) CDW earnings.jpg

A bit of history here.

In 2014/2015, CDW actually projected that they’ll have a shortage of light guide panels to meet demand. In response, CDW acquired a 25% stake in Pengfu, a company that supplies CDW with these light guide panels, which CDW then assembles into backlight units that are used in smartphones, gamesets and vehicle displays.

At that point, my investing thesis was that with Pengfu, we should see CDW meeting demand. Plus with the acquisition, Pengfu would be contractually obliged to place CDW’s orders at 1st priority. (It’s part of the contract). On top of that, prior to the acquisition, CDW has been getting light guide panels from a competitor. Pengfu would not only give CDW priority, but would charge them a lower rate as well.

Well, the acquisition has turned out to be a disaster, as the smartphone demand dried up. In my earlier posts, I described how with the divestment of Sharp to Foxconn, the orders may dry up. In M&A, the acquirer obviously has to do something different to try to turn around the fortunes of the acquired business. Otherwise, why buy?

Then there’s also the part about their BLUs going obsolete etc, I think I’ve described all that previously so I won’t repeat these.

Anyhow, fast forward a year or 2, and my fears have been realized. Looking at the earnings statement above, the “share of loss of an associate” part relates to the Pengfu acquisition. In the 2 years since the acquisition, it hasn’t been profitable at all. More worryingly, the losses have widened comparing 2015 vs 2016.

Yet EVEN more worrying is the “impairment losses of investment in an associate”, found in the 2 rows below that. Those relate to the more recent investments that the company undertook, such as the Korean company, some product rights for shampoo and other, honestly, weird investments.

If you think it’s vague that I only mentioned “Korean company”, that’s because it IS vague. There’s  no mention of the operations of this company, just that CDW will do the “manufacturing and distribution” for its products.

Normally you’d assume, ok it says “manufacturing” so it must be related to CDW’s core business of BLUs, but CDW of late has gone rogue, investing in diverse stuff from ramen restaurant to hair loss shampoo. So I’m not so sure what to infer here.

Anyway, the losses are not large, but the significance of this impairment is HUGE IMO.

Pengfu loss is OK. Nobody gets business decisions right all the time. They tried to predict a trend, got caught out when demand dried up, it happens all the time in business.

But the impairment losses on the recent investments are unrelated to the core businesses, and are… well, RECENT. Not good at all IMO.

Previously, when I was vested, I was assured by CFO that the ramen restaurant is one with a long history, has built up a regular pool of patrons, and would be a sound investment. I don’t see any impairment here, related to this ramen restaurant. So that’s good at least. (or maybe it’s not mentioned cos the sum is relatively small?)

Still on the earnings front, CDW tried to invest and capture more clients by coming up with a new generation of light guide films. Back in 2015, CDW said that they’ve teamed up with “a Taiwanese company” to come up with this new generation light guide films, and have already sent samples to potential clients for testing.

In subsequent quarters, CDW said in its ERs that the response is good, they’re optimistic of getting orders blah blah. OK, let me go dig up the specific statements.

There you go. This was in FY15Q2:

479) CDW FY15Q2 statement on new generation panels.jpg

“the Group is confident that this product will be launched in the fourth quarter”

Well, it seems they were overly confident then. Cos in 2015 Q4:

480) CDW FY15Q4 statement on new gen.jpg

Nope, not launched yet. Instead, now the statement becomes a lot more ominous.

“depending on how well the key customer and other market players perceive the Group’s new generation light guide mentioned….”

But wait! There’s a glimmer of hope. Cos in FY16Q1, it’s looking up again:

481) CDW FY16Q1 statement on new gen.jpg

Ah now we’re talking! “… were positively received by the key customer and its potential customers. Subject to market conditions and a pick up in demand, the Group expects to commence production by the second half of FY2016”

OK, so instead of the 4th quarter of 2015, now it’s pushed back by half a year to 2H16. OK, that’s still good. New product after R&D, +vely received, launch it, the turn around is in sight!

But 3 mths later, in FY16Q2 results:

482) CDW FY16Q2 statement on new gen.jpg

Sorry! Wait for “Recovery of global economy and the demand to pick up”

I can go on and on, but I think by now, you guys get the picture. As of FY16Q4, no orders, no launch, nothing. I don’t care how “positively reviewed” it is by the client. No orders = No $$$ = not good.

Anyway, just to complete the picture, in the most recent FY16Q4:

“The Group’s new generation light guide film which is suitable for smartphones, tablets and notebooks shows promise, however it may be currently limited by the strong competition faced by the Group’s key and potential customers, which hinders their willingness to invest in new models. Nonetheless, the Group will be on the lookout for suitable opportunities to promote the Group’s new generation light guide film product.”

Suddenly, the picture doesn’t look quite as rosy as “market cap supported 91% by net cash” huh.

At this point, I’ll just say that it almost sounds like I’m critical of CDW’s management.

I’m not.

CDW’s business is such that it has a major client (Sharp, although they will never confirm this). Sharp is kinda screwed now, and is still struggling to compete in the smartphone market.

CDW has long ties with this major client (I’ve described previously how the ties date back to the founder of CDW’s father era). But business is business. If CDW’s main client is suffering, CDW cannot escape. And therein lies my greatest concern: their core business possibly, may never come back. It’s been 2 years and counting, and the smartphone industry is notoriously competitive.

After the acquisition, I’m not even sure if CDW’s historical ties to it’s major client still counts for anything.

This is not something that their management can control. It’s just the nature of the business. My investing thesis then, was initially based on Pengfu, which failed. Then this new generation light guide, but that has proved to be a failure thus far as well.

To put things in perspective, they could also not announce any developments with regard to the new generation light guide. Then nobody would know if they screw up. But they did, and that’s called transparency. I really wished it ended better for the management though.

Anyhow, let me move on to the cashflows, which is really important for CDW.

478) CDW FCF.jpg

FCF has now been -ve for the past 2 years. But it’s a puny, small negative. At this rate, with CDW’s BS, it can afford to run through many years of -ve CFs, and maintain the current dividend for a looooooong time before the BS becomes stressed.

Like I said, BS is rock solid.

The business has always had minimal capex. Afterall, after you buy those machinery, they can last a pretty long time without replacement.


I guess readers, or those who have vested, will now be asking the key question:

At this point in time, is CDW Holdings a good investment then?

I can’t answer that for others. I know it’s not for me now, but previously, there’s a point in time whereby I would.

The truth is, CDW is currently almost like it’s in “cold storage” or a zombie state. If I can be permitted to describe it as such.

Basically, the company has a strong BS, and will likely be able to survive for a long long while if everything stays the same. And it’s already a depressed environment for 2 years for them.

They cut their dividends in FY16, but at current rates, they can sustain -ve CFs and maintain dividends for quite a few years to come.

That’s the good part. The bad part is that their future prospect is very uncertain.

As I’ve illustrated above, investors would do well to forget about this new generation light guide panels in your investing thesis. 2 years of “about to launch” is enough. Management is trying their best to find new revenue streams, but thus far has only “impairment losses” to show for their efforts in the recent acquisitions.

Over the years, I’ve also learnt to be very skeptical of companies that stray away from their core businesses and go into unrelated ones. It’s usually not a good sign.

On top of that, for businesses who invest in unrelated industries, it basically means that as a shareholder, you’re trusting the investing prowess of the management. And as I’ve mentioned in an earlier post, (I think it was King Wan?), I’ve stopped trusting others to do DD and invest for me. I think I’d do it better myself, thank you.

So the lowdown is this:

Imagine I come to you with an offer. I’ve a medical clinic business that was previously doing rather well. Recently, it has fallen onto tough times, but I believe the operating environment will pick up soon and my business will go back to its glory days.

In the meantime, I’m offering to sell a part of the business to you, for every $10 you pay, you get an equivalent of $9 in cash that’s parked in the business.

That’s a very good deal. The downside is, you don’t control the business operations, and yea, this $9 may be whittled down if I decide I’ll use the business to buy a… restaurant or stationary shop tomorrow.

Dividends will take up maybe $0.50 out of this $9 every year, so you know that the business would be able to pay you dividends (current yield for CDW is about 3.5% – 4%) for a long time to come.

Would you invest?

Like I said, the old, previous TTI would at least consider it. Probably such a deal would have at least a non-core place in my portfolio then. (It really did actually!) The rationale then, is to monitor the business and wait for the operating environment to improve. I know the business is strong enough and prudent enough to sustain through a long cold winter. Like Jon Snow, I don’t know how long this winter would last though.

The current TTI though, wouldn’t even give this a thought.

So is this a good investment now? I can only display the intimate facts, everyone has to decide on their own. Even within myself, my thinking has evolved over time and so has my investing characteristics of late.

Honestly, and I hope I’m not being over confident here, I think my new thoughts and investing process would show even more stellar results over time. I applied these new thoughts to the 2 most recent investments,Geo Energy and Dutech Holdings, and thus far, results have been most pleasing.

2 is hardly a big enough sample pool, with such a short duration too, so I’ll have to wait longer to assess.

On a related note, one may note that “hey TTI, you spent all this time  following up and analyzing a company that you are not vested in and already know that you won’t be vested in??”

Well, I think Buffett was most instructive when he said that the decisions that would’ve the greatest impact on his returns, are the ones that he didn’t take. But we wouldn’t know how well or poor a decision is, until we track the results AFTER the decision has been made, right? And if we don’t know, how then would we learn, and if a similar scenario crops up, how then would we make an informed choice?

Anyway, this concludes my update on CDW Holdings for now.

As always, happy hunting!

TTI’s Options Strategy – Results Thus Far In 2017

2017 has been kind to me thus far. Both my large positions in my recent investing ideas came out tops and their share prices exploded significantly.

Dutech Holdings is up about 85% since I bought it a year+ ago. I wrote about the company in June 2016, and  most recently updated my thoughts in a comprehensive series.

Dutech Holdings Investing Thesis

Dutech Holdings – What’s Next? Realize $117k Profit, Hold Or Add More? (Part I)

Massive FY16Q4 For Dutech Holdings – Digging Deep To Understand The Impact Of Metric Group Acquisition (Part II)

Dutech Holdings – What Lies Ahead? Part III

Dutech Holdings Part I’s title is no longer relevant. Cos the profit is no longer $117k with the run up. It’s more like $180k as I type this. Yet, I haven’t sold a single share.

Geo Energy Resources also performed spectacularly well, and is up a massive 75% since I bought it just 3 months ago

Geo Energy Resources Investing Thesis – Part I

Geo Energy Resources Investing Thesis Part II

Right now, I’m eagerly awaiting the upcoming earnings season to kick in (sometime this or next week), then it’s going to get real busy as I dive in to digest each result. I feel like a parent waiting for my kids’ PSLE results. These “kids” of mine are genuises. The rest of the market just hasn’t realized it yet. But they will come around eventually. Starting with PSLE.

446) option-1010899__340.jpg

I’ve also had a series of nice wins in my options strategies. I’ve utilized an option strategy for the US and other larger markets for the past 3 years or so now.

It’s been a long journey, but I’ve since developed my personal brand of strategy which has thus far (*touch wood) been working like a gem, generating consistent cashflow of between $3k-$8k USD every month for me, while putting $200k USD of capital to work.

When I started utilizing options, for a couple of months I had a series of nice wins. It encouraged me to commit more capital, and I got bolder and bolder, choosing contracts with high volatility and their accompanying large premiums, until 1 big fine day, 3 months into utilizing options, the markets turned against me and I pretty much lost ALL the gains I made… in a single night. (All thanks to Herbalife!)


That was extremely painful. I’m not used to a realized 5-digit USD loss in a SINGLE night.

Needless to say, I dived deep into analyzing my strategy and developing over the past 3 years, and now I’ve a certain brand of options strategy that is probably not commonly used, but is probably not unique to myself either. Anyhow, it works for me, and that’s all that matters.

I have previously mentioned about options in a simple guide, so if you’ve no idea what I just said, here it is:

TTI’s Basic Guide To Stock Options

Honestly, I’m not sure why very few people (to the best of my knowledge at least) utilize some form of option strategy. I guess people fear what they don’t know or understand.

But, IMO it’s really not that difficult to understand, although the specific nuances of it would probably need some experience too grasp, yet the rewards can be disproportionately large.

Best of all, I like the time decay portion. When WB bought Gillette, he said he likes to think that as America slept, there would be millions of guys waking up the next day with a bit more facial hair, needing Gillette’s products.

Well, that’s what I feel about options too. As I sleep, the liabilities (ideally) gets reduced by time decay, while I pocket the nice fat premiums and am free to re-invest the premiums.

I know that I’m not the only guy doing this, because in some of the Straits Times news feature on some investors, they mentioned something similar. There are some very wealthy individuals whom I know do something similar to what I’m doing too.

Sure, our strategies will probably differ a bit, but just from the simple few sentences they mentioned, I can tell we’re all probably on the same page somewhat.

Some of my friends have asked me to teach them in a cursory manner, and while I’ve attempted to, they don’t seem to really understand or dare to try.

I guess it’s not hard to see why. Options are derivatives with possibilities of leverage. And leverage, is akin to a bad word for many investors. It’s scary. Sure. There are horror stories everywhere when it comes to leverage.

Which is why, in my thinking, it’s all about managing risk. In fact, I had to seek advice and read some books on statistics recommended by my friend, who is an actuary. She also kindly explained to me what goes on behind the scenes when insurance companies come up with policies and how they determine their premiums. All very interesting to me.

Because, in a nutshell, my option strategy, means I’m essentially the insurance company selling insurance to anyone in the world who wants it.

In fact, my option strategy is even better. Because I can even choose to pass on the liability for the “insurance contract” to someone else, if there’s a likelihood of a claim on the insurance. Insurance companies can’t.

Of course, once in a while, stuff happens and as an “insurance company”, you’ve to start paying out. But the premiums you receive are supposed to far outweigh the payouts in the long run.

It’s all really just about stats and managing risk.

445) TTI's options.jpg

I track my options in a table that looks like this.

The “unshaded” rows are contracts that are still active, while the “shaded” ones are inactive/expired.

The coloured codes are for contracts that are related, i.e. selling and covering the same contract.

In Jan 2017, I collected a total premium of $6,819.54 USD

Amongst all the contracts, I’ve only had to cover 1 that was unprofitable. That’s the pink one for Valeant, in which I lost $43.10 USD. The rest were all highly profitable, with many contracts with high premiums totally expiring, which is kinda like an insurance policy that expired without a claim on it: the insurance company pockets the premium and kindly asks if you’d like to extend your coverage.

I’ve had 3 options assigned, resulting in a net purchase of 9,000 shares of Chesapeake Energy, and 400 shares of Valeant Pharmaceuticals.

The 9,000 shares of Chesapeake Energy though, are shares that I’ve held, and previously sold in another option contract that got exercised in Dec 2016. So I’m just sorta buying back what I’ve been contracted to sell previously.

All this while collecting premiums on both the buy and sell contracts. Fine piece of business I’d say.

The 400 shares of Valeant is a new addition to my existing position. I wasn’t contracted to sell previously. But I already have the intention to add to my Valeant position (this is recorded in the “Transactions” page) anyway, so getting this exercised is fine with me, plus I get to pocket the premium and I’ve swung to sell a Call Option on this (As shown in the table) (On a related note, I’m still getting whacked on my Valeant position, but I’m a damn stubborn guy and I still think I’m going to come out tops. We’ll see.)

You might also notice that practically all my options activities revolve around just these 2 companies.

This is because I believe that for it to be done safely, options still require the usual deep value analysis, and thorough investigation; no different from what I’d do before I’d buy the equity of the company.

Afterall, options ARE derivatives. And their intrinsic value is derived from the equity.

On a different, yet related note… (and I’m trying to illustrate something here with a real life example, not trying to identify anyone)

Around the time when my Dutech Holdings Part I thesis was posted, the share price then was around $0.45. Someone told me that I’d better sell cos the “trend is very bearish”. I very politely begged to differ. He ended with an ominous “All the best then”. (He meant it genuinely, I believe)

Now, I’d be an abject failure if my months of research into the company can’t provide me with the confidence or arrogance to dismiss naysayers. Particularly those who rely solely on the stars and godly celestial beings in the form of squiggly lines to tell them their fortune.

When the share price rose to $0.48 or thereabouts, the same guy screamed “its always wise to lock in profits when you can!”

When the share price rose yet further to $0.50, there’s a sudden change. Suddenly, he’s telling me “looks like it’d breakout! watch for it! If it does breakout, it may go higher!”

Wow. Seriously wow. That’s like a sentence only Donald Trump makes. Lots of words with absolutely zero meaning. Maybe I can come up with some of these myself:

“If it doesn’t breakout, it may go lower! But there’s also a chance it can stay flat here to provide some support! Be careful if it goes past this support though, because there’s a likelihood of it going much lower!”

Anyway, to conclude the story, finally, at $0.535 (today), he’s saying “Very bullish! This is going to go higher and higher! Likely to make new highs! Target Price: $0.XX <–“XX” is some new crazy large number that I think the gods told him.

The net effect of all this, is that NOW I’m starting to getting cautious about my Dutech position if even the gods think it’s going straight up to heaven…

The above is a true story. As ridiculous as it sounds. I edited the comments so that it’s not exactly the same, cos I don’t want to identify the individual.

In his defence, even the pros make such statements.

There’s a long statement by El-Erian some months ago about his outlook on the economy. And it’s so long it took up like 4 lines of the Bloomberg article, and basically it says “the economy can go up from here, but I won’t be surprised if it goes down either. There’s a small chance it can also flatline and trend, which investors would be wise not to discount…. blahblahblah.”

Well, not exactly like this, but similar. I tried finding the article to substantiate but it’s some time ago and I can’t pinpoint the exact title so can’t find it. But I remember sending that to some friends and we totally had a good laugh at it.

Imagine if doctors can act like that:

“There’s a chance that this radio-opaque lesion is cancer. We have to monitor it closely, but don’t be too worried because it may not even be cancerous either. It can grow and spread quickly, although I won’t be surprised if it stays the same when we take a review x-ray in future. We gotta remain vigilant though, and not forget that there’s always the likelihood of metastasis with this being fatal eventually, although at this stage this likelihood is not high.”

So when you’re on your deathbed, the doctor can tell you “I told you it can grow and spread quickly right? I told you there’s a chance it can get fatal right?”

How reassuring.